Endocrinology

Latest News

December 31st 2021

Ketogenic Diet Shows Promise as Nonpharmacologic Treatment for PCOS

By Maggie L. Shaw

December 24th 2021

Top 5 Most-Read Endocrinology Articles of 2021

By Maggie L. Shaw

December 18th 2021

Novel Growth Hormone Treatment Beneficial Among Children With Turner Syndrome

By Maggie L. Shaw

December 15th 2021

Comparing QOL Among Women With Infertility, PCOS, Obesity

By Gianna Melillo

December 10th 2021

GHD May Lead to Deteriorated Oral Health Among Children

By Maggie L. Shaw

More News

Enhanced DNA double helix

December 7th 2021

No Link Found Between PCOS, Endometrial Cancer

This new study investigated a potential link between genetically predicted polycystic ovary syndrome (PCOS) and greater risk of endometrial cancer among patients of European and Asian ancestries.

Patient receiving care

December 4th 2021

Researchers Call for Continued Multidisciplinary Care Through Adulthood in Prader-Willi Syndrome

Multidisciplinary care that includes growth hormone treatment should not cease once patients with Prader-Willi syndrome reach adulthood, according to authors of a study on care outcomes.

PCOS May Predispose Women to Higher Risk of Psychosis, Study Suggests

December 1st 2021

PCOS May Predispose Women to Higher Risk of Psychosis, Study Suggests

This new study from Finland highlights both the potential for severe psychiatric disturbances among women with polycystic ovary syndrome (PCOS) and lack of extensive knowledge of the toll of psychoses among this group.

Image of ovaries and uterus

November 28th 2021

Dietary Interventions Improve Fertility Outcomes Among Women With PCOS

This new review from China investigated the relationship between diet and fertility among women with polycystic ovary syndrome (PCOS) and provides clinical and evidence-based nutrition recommendations to help manage their reproductive health.

Image of injection being readied

November 24th 2021

Accelerated Puberty Onset Linked to Age of GH Treatment Initiation

This study from Japan investigated the impact of early initiation of growth hormone (GH) treatment on puberty onset and adult height outcome.

Silhouetted group of children

November 19th 2021

Children With GHD Experience Low Self-Esteem, Impaired Psychosocial Functioning, Study Shows

Early identification of psychosocial problems and psychotherapeutic care are critical in mitigating issues of low self-esteem and psychosocial maladjustment in children with growth hormone deficiency (GHD).

Doc palpating neck

November 15th 2021

Neck Circumference May Indicate Metabolic Risk in Women With PCOS

Neck circumference may serve as a suitable alternative to waist circumference when gauging cardiometabolic risks, outside of body mass index and waist circumference, among women with polycystic ovary syndrome (PCOS).

Depressed woman

November 13th 2021

High Rates of Anxiety, Depression Seen Among Chinese Women With PCOS

In this new study from China, investigators aimed to clarify anxiety- and depression-like symptoms and behaviors among women with polycystic ovary syndrome (PCOS).

Research

November 11th 2021

Growth Hormone Therapy Risk, Safety in Pediatric Cancer Survivors Profiled

Because treatment with growth hormone (GH), often necessitated by GH deficiency from childhood cancer, has been linked to tumorigenesis, concerns remain around its use among childhood cancer survivors.

Validated Measure Assesses the Impact of Treatment for Growth Hormone Deficiency in Children

November 6th 2021

Validated Measure Assesses the Impact of Treatment for Growth Hormone Deficiency in Children

Laura Joszt, MA

A validation of the observer-reported outcome of the Growth Hormone Deficiency-Child Impact Measure found it valid and reliable to understand the impact of treatment with growth hormone therapy.

Mental health image

November 4th 2021

QOL Similar Among Infertile Obese Women With, Without PCOS

Investigators compared physical and mental health outcomes among infertile women with and without polycystic ovary syndrome (PCOS), who were considered obese, by looking at their dietary intake, eating behavior, physical activity levels, and quality of life (QOL).

Graphic of the ovaries

October 28th 2021

Reducing Obesity, Insulin Resistance May Improve PCOS-Related Outcomes

Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine and metabolic diseases in women of childbearing age, but data that compare outcomes between obese and nonobese patients are scarce—something this study sought to remedy.

Pregnant woman

October 23rd 2021

Pregnancy May Carry Higher Risk of Abnormal Glucose Metabolism vs PCOS

This new study from Serbia compared outcomes on oral glucose tolerance tests between women who are pregnant and those who have polycystic ovary syndrome (PCOS).

Physician measuring child's height

October 21st 2021

Improvements Needed Across Growth Hormone Treatment Continuum

A new study from Turkey shows, among other results, that delayed initiation of treatment with growth hormone among pediatric patients may lead to minimal height improvements despite adherence to the therapy.

Clinical data being analyzed

October 16th 2021

Growth Hormone Treatment May Improve Sleep Efficiency in Prader-Willi Syndrome

With sleep apnea and abnormal sleep patterns typifying Prader-Willi syndrome, researchers from Sweden and Denmark theorized that treatment with growth hormone may improve both for individuals affected by the rare neurodevelopmental disease.

Ovaries

October 14th 2021

Women With PCOS May Reduce T2D Risk With Contraceptive Pill

University of Birmingham researchers point to potential benefits via reduced unbound active androgens, low levels of which increase the body’s response to insulin and decrease the likelihood of hirsutism in women with polycystic ovary syndrome (PCOS) at risk of developing type 2 diabetes (T2D).

woman at doctor's office

October 8th 2021

Acknowledging the Understudied Nature of Long-term PCOS Risks

An article looks at questions surrounding the long-term risks of polycystic ovary syndrome (PCOS).

HRT Not Linked to Increased Dementia Risk, Study Says

October 1st 2021

HRT Not Linked to Increased Dementia Risk, Study Says

Allison Inserro

A large study out of the United Kingdom finds that women who use hormone replacement therapy (HRT) do not have a higher risk of dementia.

Picture of doctor examining a child

September 30th 2021

Review Explores GHD Issues in Children, Adolescents

Allison Inserro

A recent review explored issues in diagnosing and treating children with growth hormone deficiency (GHD).

PCOS Estimated to Cost $8 Billion in Immediate, Long-term Health Issues

September 21st 2021

PCOS Estimated to Cost $8 Billion in Immediate, Long-term Health Issues

Allison Inserro

An updated report shows that the long-term cost of treating the health effects of polycystic ovary syndrome (PCOS)—$4.3 billion—is even higher than $3.7 billion it takes to diagnose and treat immediate issues that present for women who are of reproductive age.

x-ray of teeth

September 19th 2021

How Does GHD Affect the Oral, Dental Development of Children?

Allison Inserro

A systematic review that aimed to find out more about how growth hormone deficiency (GHD) affects children's oral and dental development found that knowledge gaps still remain.

Israeli Study Assesses Real-world Outcomes of Growth Hormone Treatment

September 18th 2021

Israeli Study Assesses Real-world Outcomes of Growth Hormone Treatment

Allison Inserro

Real-world outcomes can differ from those seen in tightly-controlled clinical trials, so researchers wanted to examine the patterns of growth hormone treatment in a large cohort of children in Israel.

Picture of child with doctor

September 11th 2021

Study Details Findings of Phase 3 Trial for Once-Weekly Growth Hormone

This pivotal phase 3 trial led to the recent approval of lonapegsomatropin for growth hormone deficiency.

Picture of chicks illustrating growth

September 8th 2021

Contrast Agent May Be Unnecessary in MRIs Checking Pediatric Growth

Jared Kaltwasser

A review of cases using MRI with and without contrast agent found perfect or near-perfect agreement in most cases when evaluating patients with short stature for growth hormone deficiency.

Once-a-Week Somatropin Injection Cleared for Pediatric Growth Deficiency

September 3rd 2021

Once-a-Week Somatropin Injection Cleared for Pediatric Growth Deficiency

The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections.

Machine Learning Predicts Incidence of Gestational Diabetes

December 30th 2020

Machine Learning Predicts Incidence of Gestational Diabetes

Using advanced machine learning models, researchers in China were able to accurately predict incidence of gestational diabetes among pregnant women during their first trimester.

Irregular Menstrual Cycles Associated With Increased Risk of T2D

December 28th 2020

Irregular Menstrual Cycles Associated With Increased Risk of T2D

In a cohort study of nurses, irregular and long menstrual cycles throughout life were associated with a greater risk of type 2 diabetes (T2D).

Metformin Linked to Lower COVID-19 Mortality Rates Among Women With T2D, Obesity

December 8th 2020

Metformin Linked to Lower COVID-19 Mortality Rates Among Women With T2D, Obesity

Among women hospitalized with coronavirus disease 2019 (COVID-19), use of metformin—a type 2 diabetes (T2D) drug used to manage blood sugar levels—was associated with a 21.5% lower risk of death.

New drug development in laboratory

October 23rd 2020

Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs

Christina Mattina

In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.

Handshake between pharmacist and payer

October 21st 2020

Succeeding in Value-Based Payment Requires Engaging Pharmacists From Health Plans and Systems

Christina Mattina

Pharmacists have an important role to play in the success of value-based payment models, according to panelists who discussed their health plan’s value initiatives at the Academy of Managed Care Pharmacy Nexus 2020 meeting.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions